Nymox Pharmaceutical Corporation NYMX

Annual report 2024
added 04-25-2026

Nymox Pharmaceutical Corporation DIO Ratio 2011-2026 | NYMX

Annual DIO Ratio Nymox Pharmaceutical Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	5.46	85.7	186	29.8	61.1	29.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
186	5.46	66.2

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Aptorum Group Limited APM	4.89	$ 0.9	-2.33 %	$ 6.62 M	China
	ACADIA Pharmaceuticals ACAD	295	$ 21.96	-0.68 %	$ 3.64 B	USA
	Amphastar Pharmaceuticals AMPH	166	$ 21.41	1.9 %	$ 1 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Aquestive Therapeutics AQST	120	$ 4.08	0.25 %	$ 436 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 23.26	1.75 %	$ 2.96 B	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.44	-5.88 %	$ 383 M	Britain
	BioXcel Therapeutics BTAI	1.56 K	$ 1.06	-3.64 %	$ 12.9 M	USA
	CASI Pharmaceuticals CASI	47.4	-	-	$ 35.4 M	USA
	bluebird bio BLUE	125	-	-	$ 546 M	USA